Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Abbott Laboratories buy Benchmark Co.

Abbott Laboratories
Start price
€115.06
10.10.25 / 50%
Target price
€125.35
10.10.26
Performance (%)
-13.21%
Price
€99.86
21.08.26
Summary
This prediction is currently active. The prediction for Abbott Laboratories disappoints with a performance of -13.21%. This prediction currently runs until 10.10.26. The prediction end date can be changed by Benchmark_Co_ at any time. Benchmark_Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Abbott Laboratories 3.826% 3.826%
iShares Core DAX® -1,28 % 4,21 %
iShares Nasdaq 100 -3,34 % -1,74 %
iShares Nikkei 225® -4,29 % -1,62 %
iShares S&P 500 -2,31 % -0,10 %

Comments by Benchmark_Co_ for this prediction

In the thread Discuss Abbott Laboratories
Prediction Buy
Perf. (%) -13.21%
Target price 125.353
Change
Ends at 10.10.26

Abbott Laboratories (NYSE:ABT) is now covered by analysts at Benchmark Co.. They set a "buy" rating and a $145.00 price target on the stock.
Ratings data for ABT provided by MarketBeat

Benchmark Co. 
0
Report Share
10.10.25

Stopped prediction by Benchmark_Co_ for Abbott Laboratories

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€81.24
17.04.26
€101.90
17.04.27
22.92%
21.08.26

Benchmark Co. 
17.04.26 50%